Advanced search
Publication Cover
The Application of Clinical Genetics Volume 16, 2023 - Issue
Submit an article Journal homepage
303
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report

Amina Scherz1 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-3367-4485View further author information
ORCID Icon,
Susanna Stoll2 Department of Medical Oncology, University Hospital and Stadtspital Triemli, Zurich, SwitzerlandView further author information
,
Benno Rothlisberger3 GENETICA AG, Zurich, SwitzerlandView further author information
&
Manuela Rabaglio1 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, SwitzerlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6764-1844View further author information
ORCID Icon
Pages 83-87 | Received 24 Jan 2023, Accepted 13 Apr 2023, Published online: 11 May 2023

References

  • Lynch HT, Watson P, Conway TA, Lynch JF. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat. 1990;15:63–71. doi:10.1007/BF01810778
  • Smith P, McGuffog L, Easton DF, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes Chromosomes Cancer. 2006;45(7):646–655. doi:10.1002/gcc.20330
  • Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71. doi:10.1126/science.7545954
  • Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–792. doi:10.1038/378789a0
  • Mavaddat N, Peock S, Frost D, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst. 2013;105:812–822. doi:10.1093/jnci/djt095
  • Golmard L, Delnatte C, Laugé A, et al. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. Oncogene. 2016;35(10):1324–1327. doi:10.1038/onc.2015.181
  • Tesoriero A, Andersen C, Southey M, et al. De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation. Am J Hum Genet. 1999;65:567–569. doi:10.1086/302503
  • Edwards E, Yearwood C, Sillibourne J, Baralle D, Eccles D. Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. Fam Cancer. 2009;8:479–482. doi:10.1007/s10689-009-9270-8
  • Kwong A, Ng EK, Tang EY, et al. A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer. Fam Cancer. 2011;10:233–237. doi:10.1007/s10689-011-9429-y
  • Garcia-Casado Z, Romero I, Fernandez-Serra A, et al. A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer. BMC Med Genet. 2011;12:134. doi:10.1186/1471-2350-12-134
  • De Leeneer K, Coene I, Crombez B, et al. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. Breast Cancer Res Treat. 2012;132:87–95. doi:10.1007/s10549-011-1544-9
  • Delon I, Taylor A, Molenda A, et al. A germline mosaic BRCA1 exon deletion in a woman with bilateral basal-like breast cancer. Clin Genet. 2013;84:297–299. doi:10.1111/cge.12057
  • Van der Luijt RB, van Zon PH, Jansen RP, van der Sijs-Bos CJ, Wárlám-Rodenhuis CC, Ausems MG. De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer. J Med Genet. 2001;38:102–105. doi:10.1136/jmg.38.2.102
  • Robson M, Scheuer L, Nafa K, Ellis N, Offit K. Unique de novo mutation of BRCA2 in a woman with early onset breast cancer. J Med Genet. 2002;39:126–128. doi:10.1136/jmg.39.2.126
  • Hansen TV, Bisgaard ML, Jønson L, et al. Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet. 2008;9:58. doi:10.1186/1471-2350-9-58
  • Friedman L, Ostermeyer E, Szabo C, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet. 1994;8:399–404. doi:10.1038/ng1294-399
  • Rashid M, Muhammad N, Naeemi H, et al. Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients. Int J Cancer. 2022;151:402–411. doi:10.1002/ijc.34016
  • Marshall M, Solomon S, Lawrence Wickerham D. Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer. Clin Genet. 2009;76:427–430. doi:10.1111/j.1399-0004.2009.01246.x
  • Diez O, Gutiérrez-Enríquez S, Mediano C, et al. A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer. Breast Cancer Res Treat. 2010;121:221–225. doi:10.1007/s10549-009-0494-y
  • Bonaïti B, Alarcon F, Andrieu N, et al. A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening. J Med Genet. 2014;51:114–121. doi:10.1136/jmedgenet-2013-101674
  • Van Minkelen R, van Bever Y, Kromosoeto JN, et al. A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands. Clin Genet. 2014;85:318–327. doi:10.1111/cge.12187
  • Antonucci I, Provenzano M, Sorino L, Rodrigues M, Palka G, Stuppia L. A new case of “de novo” BRCA1 mutation in a patient with early-onset breast cancer. Clin Case Report. 2017;5(3):238–240. doi:10.1002/ccr3.718

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.